Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Watchdog to probe Aviva's £3.7bn takeover of Direct Line

(Sharecast News) - The competition watchdog is to investigate Aviva's planned £3.7bn takeover of Direct Line Insurance Group, it confirmed on Wednesday. The blue chip insurer announced in December it had agreed to acquire its smaller rival after an earlier £3.3bn offer was rebuffed.

The tie-up will create a major player in the motor insurance, covering around 20% of the UK market.

Shareholders backed the deal in March, but on Wednesday the Competition & Mergers Authority confirmed it was opening an investigation into the deal.

It has therefore asked interested parties to comment, and will then assess whether the tie-up could result in a "substantial lessening of competition".

The deadline to comment by is 29 May, with findings due to be published in July.

Under the terms of the deal as it currently stands, Aviva shareholders would own around 87.5% of the new company, while Direct Line investors would hold around 12.%.

As well as it eponymous brand, Direct Line also owns Churchill and Green Flag.

As at 0930 BST, shares in both Aviva and Green Line were largely flat, at 575p and 289.4p respectively.

Both companies have yet to comment on the CMA's announcement.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.